March 25, 2026

Hospitals lose 10–20% of Medical supply procurement value due to lack of visibility, especially in high-usage injections like Ceftriaxone (Inj. GenCeft) and Cefoperazone-Sulbactam (Inj. GenCepS).  Where the Loss Happens  Area  Impact  Rate variation  8–20%  Expiry loss  2–6%  Duplicate ordering  3–8%  Financial mismatch  2–5%  High-Impact Antibiotic Injections  Why It Remains Invisible  Reality  Everything is functioning. But nothing is being measured.  Our Mission  To […]